These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17620694)

  • 41. DTPa-HBV-IPV vaccine for primary vaccination of infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C
    J Paediatr Child Health; 2007 Sep; 43(9):587-92. PubMed ID: 17688642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
    Carbone T; McEntire B; Kissin D; Kelly D; Steinschneider A; Violaris K; Karamchandani N
    Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1078-9. PubMed ID: 18830212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components.
    Zieliński A; Rosińska M
    Przegl Epidemiol; 2008; 62(3):589-96. PubMed ID: 19108523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study.
    Okada K; Ohashi Y; Matsuo F; Uno S; Soh M; Nishima S
    Epidemiol Infect; 2009 Jan; 137(1):124-30. PubMed ID: 18474125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination.
    McIntyre PB; Burgess MA; Egan A; Schuerman L; Hoet B
    Vaccine; 2009 Feb; 27(7):1062-6. PubMed ID: 19095033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactogenicity profile of tetanus-diphtheria (adult-type) vaccine: results of a naturalistic study performed at an adult vaccination center.
    Vilella A; Dal-Ré R; Simó D; García-Corbeira P; Diego P; Bayas JM
    J Clin Pharmacol; 2000 Nov; 40(11):1267-73. PubMed ID: 11075312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Song LY; Fenton T; Nachman SA; Levin MJ; Rosenblatt HM; Pelton SI; Borkowsky W; Edwards KM; Peters J;
    Pediatrics; 2007 Nov; 120(5):e1190-202. PubMed ID: 17938165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial.
    Jackson LA; Dunstan M; Starkovich P; Dunn J; Yu O; Nelson JC; Rees T; Zavitkovsky A
    Pediatrics; 2006 Mar; 117(3):620-5. PubMed ID: 16510639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adverse reactions to diphtheria-pertussis-tetanus vaccine in the Chilean Immunization Program].
    Abarca V K; Cerda L J; Ferreccio R C
    Rev Med Chil; 2009 Jan; 137(1):10-7. PubMed ID: 19399316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults.
    Hoel T; Wolter JM; Schuerman LM
    Eur J Emerg Med; 2006 Apr; 13(2):67-71. PubMed ID: 16525231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential impact of acceleration of the pertussis vaccine primary series for infants.
    Shinall MC; Peters TR; Zhu Y; Chen Q; Poehling KA
    Pediatrics; 2008 Nov; 122(5):1021-6. PubMed ID: 18977982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acellular pertussis vaccines pertinent issues.
    Mathew JL
    Indian Pediatr; 2008 Sep; 45(9):727-9. PubMed ID: 18820375
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.
    David S; Vermeer-de Bondt PE; van der Maas NA
    Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.